These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3980327)

  • 21. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
    Galante D; Esposito S; Barba D
    Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergic activity of beta-lactamines and aminoglycosides vs. bacterial strains treated with sub-MIC concentrations.
    Gismondo MR; Romeo MA; Pappalardo C; Puglisi G; Leonardi R
    Chemioterapia; 1984 Jun; 3(3):175-7. PubMed ID: 6529773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
    Braga PC; Sala MT; Mancini L; Da Sasso M
    Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
    Richmond MH
    Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killing and regrowth of bacteria in vitro: a review.
    Craig WA; Ebert SC
    Scand J Infect Dis Suppl; 1990; 74():63-70. PubMed ID: 2097720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
    Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of urine on the in vitro antimicrobial activity of various antibiotics against different Escherichia coli phenotypes.
    Büyükbaba-Boral O; Gönüllü N; Küçükbasmaci O; Anğ-Küçüker M; Anğ O
    Chemotherapy; 2004 Apr; 50(1):35-9. PubMed ID: 15084804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monitoring of uropathogens and their susceptibility to antibiotics].
    Savitskaia KI; Trapeznikova MF; Nesterova MV; Rusanova EV
    Antibiot Khimioter; 2001; 46(6):12-20. PubMed ID: 11573319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect on growth curve patterns of brief exposure of bacteria to different concentrations of beta-lactam antibiotics.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():27-36. PubMed ID: 3920184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The post-antibiotic effect defined by bacterial morphology.
    Lorian V; Ernst J; Amaral L
    J Antimicrob Chemother; 1989 Apr; 23(4):485-91. PubMed ID: 2663811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance in urinary tract infections.
    Miller TE; Fortune J; Brnham S
    N Z Med J; 1975 Jun; 81(542):552-7. PubMed ID: 1057747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of new antibiotics in the treatment of infectious diseases of the urinary organs caused by gram negative bacteria].
    Marshak AM; Iakovlev VP; Lur'e LA
    Urol Nefrol (Mosk); 1973; 38(4):5-7. PubMed ID: 4787122
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical investigation of isolated bacteria from urinary tracts of hospitalized patients and their susceptibilities to antibiotics.
    Shigemura K; Arakawa S; Tanaka K; Fujisawa M
    J Infect Chemother; 2009 Feb; 15(1):18-22. PubMed ID: 19280295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative urinary bactericidal activity of oral antibiotics against gram-positive pathogens].
    Bedenić B; Budimir A; Gverić A; Plecko V; Vranes J; Bubonja-Sonje M; Kalenić S
    Lijec Vjesn; 2012; 134(5-6):148-55. PubMed ID: 22930932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.